Tsukuba, Japan

Mitsuru Kuribayashi

This inventor holds 9 USPTO granted patents and 3 EPO patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1998-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuru Kuribayashi. Retrieved from https://idiyas.com/inventor/mitsuru-kuribayashi-gnmnv1xy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 77.8


Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 133(Granted Patents)


Location History:

  • Tosu, JP (1998)
  • Tsukuba, JP (1999 - 2010)
  • Ibaraki, JP (2013)

Company Filing History:


Years Active: 1998-2013

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mitsuru Kuribayashi: Innovator in Transdermal Drug Delivery

Introduction

Mitsuru Kuribayashi, based in Tsukuba, Japan, is a prominent inventor known for his significant contributions to the field of pharmaceutical innovations. With an impressive portfolio of 9 patents, Kuribayashi has focused on enhancing drug delivery systems, particularly through transdermal applications.

Latest Patents

Kuribayashi's latest inventions include a "Transdermally absorbable preparation," which addresses the challenge of poor solubility in drug formulations by ensuring stability over time while suppressing crystallization. This innovative preparation includes composite particles made up of a silicate compound, an organic acid, and a drug to optimize transdermal absorbability. Additionally, he developed a "Drug-containing patch" that presents an effective solution for percutaneous absorbability and sustainability of the drug’s efficacy. This patch comprises a drug, a melting point lowering agent, and an adhesive base, making it suitable for therapeutic use in patients.

Career Highlights

Currently, Mitsuru Kuribayashi is affiliated with Hisamitsu Pharmaceutical Company, Inc., where he continues to pioneer advancements in transdermal drug delivery systems. His work has been instrumental in enhancing therapeutic outcomes for patients needing effective and reliable drug administration methods.

Collaborations

Throughout his career, Kuribayashi has collaborated with notable colleagues, including Naruhito Higo and Hiroyuki Maeda. These partnerships have contributed to the successful development of innovative drug delivery solutions.

Conclusion

Mitsuru Kuribayashi exemplifies the spirit of innovation in the pharmaceutical industry. His continuous efforts to develop advanced transdermal systems will likely inspire future breakthroughs in drug delivery, ultimately benefiting patients around the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…